BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 11684669)

  • 1. lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans.
    Boxem M; van den Heuvel S
    Development; 2001 Nov; 128(21):4349-59. PubMed ID: 11684669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of postembryonic G(1) cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex.
    Park M; Krause MW
    Development; 1999 Nov; 126(21):4849-60. PubMed ID: 10518501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C. elegans class B synthetic multivulva genes act in G(1) regulation.
    Boxem M; van den Heuvel S
    Curr Biol; 2002 Jun; 12(11):906-11. PubMed ID: 12062054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental regulation of a cyclin-dependent kinase inhibitor controls postembryonic cell cycle progression in Caenorhabditis elegans.
    Hong Y; Roy R; Ambros V
    Development; 1998 Sep; 125(18):3585-97. PubMed ID: 9716524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential embryonic roles of the CKI-1 cyclin-dependent kinase inhibitor in cell-cycle exit and morphogenesis in C elegans.
    Fukuyama M; Gendreau SB; Derry WB; Rothman JH
    Dev Biol; 2003 Aug; 260(1):273-86. PubMed ID: 12885569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells.
    The I; Ruijtenberg S; Bouchet BP; Cristobal A; Prinsen MB; van Mourik T; Koreth J; Xu H; Heck AJ; Akhmanova A; Cuppen E; Boxem M; Muñoz J; van den Heuvel S
    Nat Commun; 2015 Jan; 6():5906. PubMed ID: 25562820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin-dependent kinase inhibitors, cki-1 and cki-2, act in overlapping but distinct pathways to control cell cycle quiescence during C. elegans development.
    Buck SH; Chiu D; Saito RM
    Cell Cycle; 2009 Aug; 8(16):2613-20. PubMed ID: 19597327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional control of cell-cycle quiescence during C. elegans development.
    Clayton JE; van den Heuvel SJ; Saito RM
    Dev Biol; 2008 Jan; 313(2):603-13. PubMed ID: 18082681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
    Leng X; Connell-Crowley L; Goodrich D; Harper JW
    Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.
    Brugarolas J; Bronson RT; Jacks T
    J Cell Biol; 1998 Apr; 141(2):503-14. PubMed ID: 9548727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lin-35/Rb and RNAi pathways cooperate to regulate a key cell cycle transition in C. elegans.
    Ouellet J; Roy R
    BMC Dev Biol; 2007 Apr; 7():38. PubMed ID: 17466069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDC-25.1 controls the rate of germline mitotic cell cycle by counteracting WEE-1.3 and by positively regulating CDK-1 in Caenorhabditis elegans.
    Yoon S; Kawasaki I; Shim YH
    Cell Cycle; 2012 Apr; 11(7):1354-63. PubMed ID: 22421141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.